RESUMO
Previously, management of hypertension has concentrated on lowering elevated blood pressure. However, the target has shifted to reducing absolute cardiovascular (CV) risk. It is estimated that two in three Australian adults have three or more CV risk factors at the same time. Moderate reductions in several risk factors can, therefore, be more effective than major reductions in one. When managing hypertension, therapy should be focused on medications with the strongest evidence for CV event reduction, substituting alternatives only when a primary choice is not appropriate. Hypertension management guidelines categorise angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) interchangeably as first-line treatments in uncomplicated hypertension. These medications have different mechanisms of action and quite different evidence bases. They are not interchangeable and their prescription should be based on clinical evidence. Despite this, currently ARB prescriptions are increasing at a higher rate than those for ACEI and other antihypertensive classes. Evidence that ACEI therapy prevents CV events and death, in patients with coronary artery disease or multiple CV risk factors, emerged from the European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA) and Heart Outcomes Prevention Evaluation (HOPE) trials respectively. The consistent benefit has been demonstrated in meta-analyses. The clinical trial data for ARB are less consistent, particularly regarding CV outcomes and mortality benefit. The evidence supports the use of ACEI (Class 1a) compared with ARB despite current prescribing trends.
Assuntos
Antagonistas de Receptores de Angiotensina/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Anti-Hipertensivos/uso terapêutico , Doenças Cardiovasculares/tratamento farmacológico , Hipertensão/tratamento farmacológico , Comportamento de Redução do Risco , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/epidemiologia , Humanos , Hipertensão/diagnóstico , Hipertensão/epidemiologia , Adesão à Medicação , Guias de Prática Clínica como Assunto/normas , Fatores de RiscoRESUMO
Tissue factor (TF) expression is associated with life-threatening thrombosis in a variety of human diseases, including sepsis, cancer, and atherosclerosis. Recently, it was shown that inactivation of the murine TF (mTF) gene results in embryonic lethality. To date, despite extensive studies on the regulation of the TF promoter in vitro, no studies have examined the cis-acting regulatory elements that control TF gene expression in vivo. Here we report that a human TF (hTF) minigene containing the human TF promoter and human TF cDNA directed a low level (approximately 1% relative to mouse TF) of both constitutive and LPS-inducible human TF expression in transgenic mice. Importantly, the human TF minigene rescued the embryonic lethality of murine TF null embryos, suggesting that human TF substituted for murine TF during embryogenesis. Rescued mice (mTF-/-, hTF+), which expressed low levels (approximately 1%) of TF activity, developed normally with no signs of a bleeding diathesis, suggesting that low TF expression can maintain hemostasis compatible with normal survival. These studies establish a novel mouse model system that can be used to examine the regulation of the human TF gene in vivo and the impact of low TF levels on the hemostatic balance in various thrombotic diseases.
Assuntos
Hemostáticos/metabolismo , Tromboplastina/metabolismo , Animais , Feminino , Expressão Gênica , Hemostasia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Tromboplastina/biossíntese , Tromboplastina/genética , Distribuição TecidualRESUMO
Recognition of bacterial endotoxin (LPS) elicits multiple host responses, including activation of cells of the innate immune system. LPS exposure occurs repeatedly during septicemia, making strict regulation of gene expression necessary. Such regulation might prevent, for example, the continuous production of proinflammatory cytokines such as tumor necrosis factor (TNF), which could lead to severe vascular collapse. Tolerance to LPS is characterized by a diminished production of TNF during prolonged exposure to LPS, and is therefore likely to represent an essential control mechanism during sepsis. In the present study, which uses mice with genetic deletions of the proteins of NF-kappaB complex, we provide data demonstrating that increased expression of the p50 subunit of NF-kappaB directly results in the downregulation of LPS-induced TNF production. This contention is supported by the following observations: (1) tolerance to LPS is not induced in macrophages from p50-/- mice; (2) long-term pretreatment with LPS does not block synthesis of TNF mRNA in p50-/- macrophages (in contrast to wild-type macrophages); (3) ectopic overexpression of p50 reduces transcriptional activation of the murine TNF promoter; and (4) analysis of the four kappaB sites from the murine TNF promoter demonstrates that binding of p50 homodimers to the positively acting kappaB3 element is associated with development of the LPS-tolerant phenotype. Thus, p50 expression plays a key role in the development of LPS tolerance.
Assuntos
Imunidade Inata/fisiologia , Macrófagos Peritoneais/imunologia , NF-kappa B/imunologia , Animais , Células Cultivadas , Regulação para Baixo , Tolerância Imunológica , Lipopolissacarídeos/imunologia , Lipopolissacarídeos/farmacologia , Macrófagos Peritoneais/efeitos dos fármacos , Camundongos , Camundongos Knockout , Subunidade p50 de NF-kappa B , Regiões Promotoras Genéticas , RNA Mensageiro , Fator de Necrose Tumoral alfa/genéticaRESUMO
Tissue factor pathway inhibitor (TFPI) was demonstrated in the kidneys of normal rabbits and in a crescentic model of glomerulonephritis (GN), where fibrin is a key mediator of injury. In normal kidneys, TFPI was expressed in glomeruli, in intrarenal arteries and the interstitial capillary network. Evidence for TFPI synthesis in vivo was provided by in situ demonstration of TFPI mRNA in glomeruli and intrarenal vessels and by biosynthetic labeling of TFPI released from glomeruli in vitro. In fibrin-dependent crescentic GN, glomerular TFPI synthesis and expression was initially decreased (TFPI antigen at 24 h, 7.5 +/- 0.7 ng/10(3) glomeruli; normal, 11.1 +/- 0.9 ng/10(3) glomeruli, P < 0.02) and subsequently returned to normal values. Plasma TFPI levels increased progressively throughout the evolution of disease. In vivo inhibition of TFPI using an anti-TFPI antibody during the development of GN significantly increased glomerular fibrin deposition (GFD) and exacerbated renal impairment. Infusion of recombinant human TFPI significantly reduced development of GFD (fibrin scores, TFPI treated 0.82 +/- 0.11, control 1.49 +/- 0.14, P < 0.01), proteinuria and renal impairment. This data indicates that TFPI is synthesized and expressed in normal glomeruli and is down regulated in the early response to glomerular injury. Endogenous glomerular TFPI and treatment with recombinant TFPI reduces GFD and injury in fibrin dependent GN. TFPI has the potential to be of therapeutic benefit in the management of fibrin dependent human GN.
Assuntos
Anticoagulantes/farmacologia , Glomerulonefrite/fisiopatologia , Rim/metabolismo , Lipoproteínas/biossíntese , Lipoproteínas/farmacologia , Animais , Fibrina/análise , Fibrina/biossíntese , Expressão Gênica , Glomerulonefrite/patologia , Glomerulonefrite/prevenção & controle , Humanos , Rim/patologia , Glomérulos Renais/metabolismo , Glomérulos Renais/patologia , Masculino , RNA Mensageiro/análise , RNA Mensageiro/biossíntese , Coelhos , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/farmacologia , Valores de Referência , Transcrição GênicaRESUMO
BACKGROUND: Magnetic resonance spectroscopy studies have suggested above-normal turnover of membrane phospholipids in brains of patients with schizophrenia. One possible explanation for these findings is increased activity of the phospholipid-catabolizing enzyme phospholipase A2 (PLA2). However, attempts to demonstrate higher PLA2 activity in the serum of subjects with schizophrenia have led to conflicting results. We hypothesized that this was due to serum PLA2 activity consisting of a family of different enzymes, with each group of investigators measuring activity of different PLA2 forms. DESIGN: Activity of PLA2 in serum samples obtained from 24 individuals with schizophrenia was compared with serum obtained from 33 age- and sex-matched control subjects, using both fluorometric and radiometric assays with different substrates. Each method had previously yielded conflicting results concerning the status of the enzyme in schizophrenia. RESULTS: With the fluorometric assay, serum PLA2 activity in individuals with schizophrenia was markedly increased by 49% compared with control subjects (P < .001). In contrast, radiometric assay of the same serum samples resulted in PLA2 activity not significantly different between patients and control subjects. Further investigations demonstrated that, whereas the radiometric assay measured activity of a calcium-dependent enzyme, the fluorometric assay detected a calcium-insensitive enzyme possessing an acid-neutral pH optimum. CONCLUSIONS: Increased calcium-independent PLA2 activity was seen in the serum of patients with schizophrenia. This change, if present also in the brain, may well explain the increased levels of phosphodiesters observed using magnetic resonance spectroscopy and therefore may contribute to the pathophysiological features of the disorder.
Assuntos
Fosfolipases A/sangue , Fosfolipídeos/metabolismo , Esquizofrenia Paranoide/enzimologia , Adulto , Idoso , Encéfalo/fisiopatologia , Cloreto de Cálcio/análise , Feminino , Fluorometria , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Fosfolipases A/análise , Fosfolipases A/classificação , Fosfolipases A2 , Fosfolipídeos/fisiologia , Escalas de Graduação Psiquiátrica/estatística & dados numéricos , Radiometria , Esquizofrenia Paranoide/metabolismo , Esquizofrenia Paranoide/fisiopatologia , Psicologia do EsquizofrênicoRESUMO
To determine whether increased oxidative stress in substantia nigra of patients with idiopathic Parkinson's disease might be related to decreased ability of nigral cells to detoxify oxidized membrane phospholipids, we compared levels of the major phospholipid metabolizing enzymes in autopsied substantia nigra with those in non-nigral (n = 11) brain areas of the normal human brain. Whereas most enzymes possessed a relatively homogeneous distribution, the activity of the major phospholipid catabolizing enzyme phospholipase A2, assayed in the presence of calcium ions, varied amongst different regions, with substantia nigra possessing the lowest activity. Similarly, calcium-independent phospholipase A2 activity, although possessing a relatively homogeneous regional distribution, was also low in the substantia nigra. This, coupled with low activity of phosphoethanolamine- and phosphocholine-cytidylyltransferases, major regulatory enzymes of phospholipid synthesis, in this brain region, suggest that the rate of phospholipid turnover is low in the substantia nigra. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra might result in reduced ability to repair oxidative membrane damage, as may occur in Parkinson's disease.
Assuntos
Enzimas/metabolismo , Fosfolipídeos/metabolismo , Substância Negra/metabolismo , Aciltransferases/metabolismo , Idoso , Cadáver , Humanos , Lisofosfolipase/metabolismo , Pessoa de Meia-Idade , Doença de Parkinson/metabolismo , Fosfolipases A/metabolismo , Fosfolipases A2 , Diester Fosfórico Hidrolases/metabolismo , Valores de ReferênciaRESUMO
High circulating levels of the procoagulant molecule tissue factor (TF) are associated with thrombosis in a variety of diseases including unstable angina, cancer, and sepsis. Currently, there are no clinical assays to measure the level of TF activity in whole blood. We present an assay called Tissue Factor Clotting Time ("TiFaCT") that detects fibrin formation in human blood. The mean baseline clotting time in a healthy population was 472 +/- 94 s (mean +/- SD, n = 150). Bacterial lipopolysaccharide (LPS or endotoxin) shortened the clotting time in a time-dependent manner. Inhibitory anti-TF antibodies prolonged the clotting time of LPS-stimulated blood, indicating that the shortened clotting time was due to induction of TF expression. Patients with unstable angina had shortened mean baseline clotting time (284 +/- 86, n = 13) compared with healthy volunteers (474 +/- 98, n = 30), suggesting that these patients had elevated levels of circulating TF. The TiFaCT assay should prove clinically useful in quantifying the levels of circulating TF in patients at risk of thrombosis.
Assuntos
Análise Química do Sangue/métodos , Tromboplastina/análise , Adulto , Idoso , Angina Instável/sangue , Angina Instável/complicações , Animais , Anticorpos/farmacologia , Endotoxemia/sangue , Estudos de Avaliação como Assunto , Feminino , Humanos , Técnicas In Vitro , Lipopolissacarídeos/toxicidade , Masculino , Pessoa de Meia-Idade , NF-kappa B/antagonistas & inibidores , Tempo de Tromboplastina Parcial , Tempo de Protrombina , Coelhos , Proteínas Recombinantes/farmacologia , Valores de Referência , Fatores de Risco , Tromboplastina/antagonistas & inibidores , Tromboplastina/farmacologia , Trombose/sangue , Trombose/etiologiaRESUMO
BACKGROUND: Aboriginal children in central Australia have attack rates for acute lower respiratory tract infection (ALRI) that are similar to those in developing countries. Although mortality rates are much lower than in developing countries, morbidity is high and ALRI is still the leading cause of hospitalization. However, there are no data on the etiology of ALRI in this population. METHODS: We prospectively studied 322 cases of ALRI in 280 Aboriginal children admitted to the hospital. Blood, urine and nasopharyngeal aspirate samples were examined for evidence of bacterial, viral and chlamydial infection. RESULTS: The combination of blood culture, viral studies and chlamydial serology provided at least 1 etiologic agent in 170 of 322 (52.5%) cases. Assays for pneumolysin immune complex and pneumolysin antibody increased etiologic diagnosis to 219 (68.0%). Blood cultures were positive in 6% but pneumolysin immune complex and pneumolysin antibody studies were positive in one-third of cases. Evidence of viral infection was present in 155 (48%) of cases compared with 12% in controls (P < 001). There were only 7 possible cases and 2 definite cases of Chlamydia trachomatis and 3 cases of Chlamydia pneumoniae. Coinfection was common in these children. CONCLUSION: These findings have implications for both standard treatment protocols and vaccine strategies. The high rate of coinfection may make it difficult to develop simple clinical predictors of bacterial infection. In the setting of a developed country with efficient patient evacuation services, management algorithms that focus on disease severity and need for hospital referral will be most useful to health staff in remote communities. Pneumococcal conjugate vaccines will be required to reduce the high attack rate of pneumococcal disease.
Assuntos
Infecções Bacterianas/etnologia , Havaiano Nativo ou Outro Ilhéu do Pacífico , Infecções Respiratórias/microbiologia , Viroses/etnologia , Austrália/epidemiologia , Bactérias/isolamento & purificação , Infecções Bacterianas/microbiologia , Proteínas de Bactérias , Pré-Escolar , Chlamydia/isolamento & purificação , Infecções por Chlamydia/etnologia , Infecções por Chlamydia/microbiologia , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Estudos Prospectivos , Infecções Respiratórias/etnologia , Infecções Respiratórias/virologia , Manejo de Espécimes/métodos , Estreptolisinas/análise , Viroses/virologia , Vírus/isolamento & purificaçãoRESUMO
Feces from 169 children admitted with diarrhea to Alice Springs Hospital, were screened for enterotoxigenic E. coli (ETEC) using specific DNA probes. E. coli which hybridized with probes for ST-P, ST-H and LT were confirmed by bioassay for toxin production. Fifty children were shown to excrete ETEC. The probes for LT correlated well with bioassay; however, probes for ST-H and ST-P hybridized with more E. coli than were shown to produce toxin by bioassay. When probing for ST was repeated using a synthetic oligonucleotide probe, only those specimens which were bioassay-positive hybridized with the probe.
Assuntos
Enterotoxinas/toxicidade , Infecções por Escherichia coli/diagnóstico , Escherichia coli/genética , DNA/análise , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/patologia , Fezes/microbiologia , Vetores Genéticos , Humanos , Hibridização de Ácido Nucleico , Oligonucleotídeos , PlasmídeosRESUMO
We report the first case of an acute pyogenic intramedullary cervical spinal cord abscess, brain abscesses and meningitis due to an unusual anerobe, Bacteroides disiens. The importance of spinal magnetic resonance imaging for establishing the diagnosis is emphasized.
Assuntos
Abscesso , Infecções por Bacteroides , Doenças da Medula Espinal , Abscesso/complicações , Abscesso/diagnóstico , Abscesso/microbiologia , Infecções por Bacteroides/complicações , Infecções por Bacteroides/diagnóstico , Infecções por Bacteroides/microbiologia , Abscesso Encefálico/complicações , Humanos , Imageamento por Ressonância Magnética , Masculino , Meningite/complicações , Pessoa de Meia-Idade , Doenças da Medula Espinal/complicações , Doenças da Medula Espinal/diagnóstico , Doenças da Medula Espinal/microbiologiaRESUMO
Norwalk-like viruses (NLVs) have now been found to be important causes of gastroenteritis amongst infants and young children as well as older children and adults. Although detected, such viruses appeared not to be a major cause amongst infants and young children hospitalized with gastroenteritis in Alice Springs, central Australia over the period January 1995-December 1997. Nine NLV-positive cases were identified amongst stools from 360 different patients. From the nine cases however, eight different NLV strains were identified from comparisons of the sequence of a section of the RNA polymerase gene, and a high degree of genomic diversity was evident amongst them. In general, these strains were more similar to those identified in other countries than to those identified in central Australia over the three year period. Of the strains identified, six (and most probably seven) were classified in genogroup I, while only one was classified in genogroup II. This predominance of genogroup I strains is in contrast to most of the more recent findings made elsewhere, including those made in other parts of Australia. Phylogenetic analysis indicated that the central Australian strains spanned a range of known representative NLV strains, with one of the genogroup I strains showing a 96% nucleotide identity to Saratoga virus.
Assuntos
Infecções por Caliciviridae/virologia , Gastroenterite/virologia , Genoma Viral , Vírus Norwalk/genética , Sequência de Aminoácidos , Austrália , Infecções por Caliciviridae/epidemiologia , Pré-Escolar , Fezes/virologia , Gastroenterite/epidemiologia , Humanos , Lactente , Dados de Sequência Molecular , Vírus Norwalk/classificação , Vírus Norwalk/isolamento & purificação , Filogenia , RNA Viral/análise , População Rural , Alinhamento de SequênciaRESUMO
When nasopharyngeal secretions from 171 Australian Aboriginal children hospitalized with acute lower respiratory tract infections (ALRI) were cultured selectively for Streptococcus pneumoniae and Haemophilus influenzae, 136 (79.5%) and 151 (88.3%) children yielded 166 and 254 isolates of S. pneumoniae and H. influenzae, respectively. In colonized subjects multiple populations of S. pneumoniae (20% of carriage-positive patients) and H. influenzae (55%) were common. Pneumococci belonging to 27 types or groups were identified. H. influenzae serotype b colonized 16.4% of all children studied. More than one half of 152 children tested were excreting antibiotics at the time of admission to hospital. Significantly fewer children with serum antibiotic residues were colonized with S. pneumoniae than were antibiotic free children. Antibiotic usage had no measurable impact on the isolation rate of H. influenzae.
Assuntos
Portador Sadio/etnologia , Portador Sadio/microbiologia , Infecções por Haemophilus/etnologia , Infecções por Haemophilus/microbiologia , Haemophilus influenzae , Hospitalização , Controle de Infecções , Nasofaringe/microbiologia , Havaiano Nativo ou Outro Ilhéu do Pacífico , Infecções Pneumocócicas/etnologia , Infecções Pneumocócicas/microbiologia , Infecções Respiratórias/etnologia , Infecções Respiratórias/microbiologia , Doença Aguda , Antibacterianos/sangue , Antibacterianos/uso terapêutico , Portador Sadio/sangue , Portador Sadio/tratamento farmacológico , Criança , Pré-Escolar , Monitoramento de Medicamentos , Resíduos de Drogas , Uso de Medicamentos , Feminino , Infecções por Haemophilus/sangue , Infecções por Haemophilus/tratamento farmacológico , Haemophilus influenzae/classificação , Humanos , Lactente , Recém-Nascido , Masculino , Infecções Pneumocócicas/sangue , Infecções Pneumocócicas/tratamento farmacológico , Grupos Raciais , Infecções Respiratórias/sangue , Infecções Respiratórias/tratamento farmacológico , Sorotipagem , Streptococcus pneumoniae/classificaçãoRESUMO
Increased glomerular tissue factor (TF) expression is associated with glomerular fibrin deposition and renal failure in human and experimental crescentic glomerulonephritis (GN). However, the in vivo functional contribution of TF to the development of glomerular fibrin deposition, crescent formation, and renal failure in GN has not been established. The contribution of TF to fibrin deposition and renal injury was studied in a rabbit model of crescentic GN in which glomerular macrophage infiltration, augmented TF expression, and fibrin deposition are prominent. Administration of anti-TF antibody inhibited glomerular TF activity in nephritic glomeruli by 96%, without affecting macrophage accumulation or systemic indices of coagulation. Anti-TF antibody significantly reduced glomerular fibrin deposition (fibrin scores, 0.43 +/- 0.10 (treated) and 1.40 +/- 0.19 (control); P < 0.0005), crescent formation (0.33 +/- 0.05 (treated) and 1.0 +/- 0.06 (control); P < 0.0005), and development of renal failure (serum creatinine, 168 +/- 22 mumol/l (treated) and 267 +/- 35 mumol/l (control); P < 0.04). This was associated with significant reduction in proteinuria (1189 +/- 277 mg/24 hours (treated) and 2060 +/- 336 mg/24 hours (control); P < 0.03) and expression of MHC class II antigen in glomeruli (1.25 +/- 0.41 (treated) and 2.83 +/- 0.53 (control); P < 0.03) and in tubules and interstitial areas. These data demonstrate that TF is the major in vivo initiator of fibrin deposition in crescentic GN. The reduction in proteinuria and glomerular major histocompatibility class II antigen expression by TF inhibition suggests that TF may also activate other mediators that contribute to glomerular injury.
Assuntos
Fibrina/metabolismo , Glomerulonefrite/metabolismo , Antígenos de Histocompatibilidade Classe II/biossíntese , Glomérulos Renais/metabolismo , Tromboplastina/fisiologia , Animais , Anticorpos/administração & dosagem , Coagulação Sanguínea/efeitos dos fármacos , Glomerulonefrite/patologia , Imunoconjugados/administração & dosagem , Glomérulos Renais/patologia , Masculino , Proteinúria/tratamento farmacológico , Coelhos , Insuficiência Renal/tratamento farmacológicoRESUMO
We examine the behavior of gravity in brane theories with extra dimensions in a nonfactorizable background geometry. We find that for metrics which are asymptotically flat far from the brane there is a resonant graviton mode at zero energy. The presence of this resonance ensures quasilocalization of gravity, whereby at intermediate scales the gravitational laws on the brane are approximately four dimensional. However, for scales larger than the lifetime of the graviton resonance the five-dimensional laws of gravity will be reproduced due to the decay of the four-dimensional graviton. We also give a simple classification of effective gravity theories for general background geometries.
RESUMO
Shigellosis is endemic in Central Australia and the infections are predominantly due to Shigella flexneri 6, Shigella flexneri 2a and Shigella sonnei. Plasmid profiles of isolates collected from 1985-9, suggested that infections caused by Shigella flexneri 6 were predominantly due to a single clone, whereas those caused by Shigella flexneri 2a and Shigella sonnei were due to several genetically diverse strains, although strains with identical plasmid profiles were found in widely separated geographical areas and in different years.
Assuntos
Disenteria Bacilar/epidemiologia , Plasmídeos , Shigella flexneri/genética , Shigella sonnei/genética , Austrália/epidemiologia , DNA Bacteriano/análise , Disenteria Bacilar/microbiologia , Eletroforese em Gel de Ágar , HumanosRESUMO
Fibrin is an important mediator of injury in severe proliferative forms of glomerulonephritis (GN). Normal glomeruli express fibrinolytic activity, which may protect against the injurious effects of fibrin deposition. Changes in glomerular fibrinolytic activity (GFA) may play an important role in modulating fibrin accumulation in GN. To study the changes in GFA associated with fibrin deposition in GN, autologous phase anti-glomerular basement antibody initiated GN (anti-GBM GN) was studied in rabbits. Net GFA was significantly reduced in association with glomerular fibrin deposition (1.3 +/- 0.8 ng fibrin lysed/10(3) glomeruli/2 hr, normal 57.1 +/- 25.4 ng fibrin lysed/10(3) glomeruli/2 hr, P < 0.02). Reduced GFA in fibrin associated GN was associated with decreased expression of tissue type plasminogen activator (tPA) and increased expression of plasminogen activator inhibitor type-1 (PAI-1) and glomerular macrophage infiltration. In a fibrin independent model of anti-GBM induced GN (heterologous phase), with equivalent injury (proteinuria), net GFA was increased (174 +/- 64 ng fibrin lysed/10(3) glomeruli/2 hr). This was associated with increased tPA and uPA, and decreased PAI-1 in the absence of significant macrophage infiltration. These studies demonstrate that fibrin deposition in GN is associated with a net reduction of GFA, attributable to reduced expression of plasminogen activators and augmentation of PAI-1. Reduction of GFA may potentiate glomerular fibrin deposition and consequent glomerular injury. The association between glomerular macrophage influx and reduction in GFA suggests that this change may be directed by macrophages.
Assuntos
Fibrinólise , Glomerulonefrite/metabolismo , Glomérulos Renais/metabolismo , Animais , Anticorpos/administração & dosagem , Antígenos/metabolismo , Membrana Basal/imunologia , Regulação para Baixo , Glomerulonefrite/etiologia , Glomérulos Renais/imunologia , Macrófagos/metabolismo , Masculino , Plasminogênio/metabolismo , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Coelhos , Ativador de Plasminogênio Tecidual/imunologia , Ativador de Plasminogênio Tecidual/metabolismo , Ativador de Plasminogênio Tipo Uroquinase/metabolismoRESUMO
Streptococcus pneumoniae strains isolated from 203 episodes of invasive disease in central Australian Aborigines were studied. Capsular types from children aged 0 to 4 years (n = 89) belonged most commonly to types 14, 6B, 9V, 4, 18C, and 19F, which together accounted for 67% of the pediatric strains. In adults (n = 98), types 1, 7F, 3, 4, 12F, and 8 contributed 68% of the isolates. Of 114 pneumococci from patients 5 years and older, 102 (89.5%) were types represented in the 23-valent pneumococcal polysaccharide vaccine. The MICs of five antibiotics were determined for 201 strains by using the E-Test (AB Biodisk). No chloramphenicol or ceftriaxone resistance was found, but 46 strains (22.9%) showed diminished susceptibility to one or more of the drugs penicillin, erythromycin, and trimethoprim-sulfamethoxazole. Penicillin resistance occurred in 15.4% of all isolates tested but only within the intermediate range (0.1 to 1.0 microgram/ml). Resistance to trimethoprimsulfamethoxazole affected 13.9% of the pneumococci tested. All type 23F and most type 19F organisms were resistant to one or more antibiotics. Resistance was significantly more common in pediatric isolates than in those from adults (chi 2(1) = 14.1; P < 0.001).
Assuntos
Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/microbiologia , Streptococcus pneumoniae/classificação , Adolescente , Adulto , Austrália/epidemiologia , Técnicas de Tipagem Bacteriana , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/farmacologia , Criança , Pré-Escolar , Resistência Microbiana a Medicamentos , Humanos , Lactente , Recém-Nascido , Pessoa de Meia-Idade , Havaiano Nativo ou Outro Ilhéu do Pacífico , Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas , Polissacarídeos Bacterianos/imunologia , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/isolamento & purificaçãoRESUMO
Damage to brain membrane phospholipids may play an important role in the pathogenesis of Alzheimer's disease (AD); however, the critical metabolic processes responsible for the generation and repair of membrane phospholipids affected by the disease are unknown. We measured the activity of key phospholipid catabolic and anabolic enzymes in morphologically affected and spared areas of autopsied brain of patients with AD and in matched control subjects. The activity of the major catabolic enzyme phospholipase A2 (PLA2), measured in both the presence and absence of Ca2+, was significantly decreased (-35 to -53%) in parietal and temporal cortices of patients with AD. In contrast, the activities of lysophospholipid acyltransferase, which recycles lysophospholipids into intact phospholipids, and glycerophosphocholine phosphodiesterase, which returns phospholipid catabolites to be used in phospholipid resynthesis, were increased by approximately 50-70% in the same brain areas. Brain activities of enzymes involved in de novo phospholipid synthesis (ethanolamine kinase, choline kinase, choline phosphotransferase, phosphoethanolamine cytidylyltransferase, and phosphocholine cytidylyltransferase) were either normal or only slightly altered. The activities of PLA2 and acyltransferase were normal in the degenerating cerebellum of patients with spinocerebellar atrophy type 1, whereas the activity of glycerophosphocholine phosphodiesterase was reduced, suggesting that the alterations in AD brain were not nonspecific consequences of neurodegeneration. Our data suggest that compensatory phospholipid metabolic changes are present in AD brain that reduce the rate of phospholipid loss via both decreased catabolism (PLA2) and increased phospholipid resynthesis (acyltransferase and glycerophosphocholine phosphodiesterase).
Assuntos
Doença de Alzheimer/enzimologia , Encéfalo/enzimologia , Fosfolipases A/metabolismo , Fosfolipídeos/metabolismo , Diester Fosfórico Hidrolases/metabolismo , Aciltransferases/metabolismo , Idoso , Cálcio/farmacologia , Colina Quinase/metabolismo , Colina-Fosfato Citidililtransferase/metabolismo , Feminino , Humanos , Lisofosfolipase/metabolismo , Masculino , Especificidade de Órgãos , Fosfolipases A2 , Fosfotransferases/metabolismo , Fosfotransferases (Aceptor do Grupo Álcool)/metabolismo , Valores de Referência , Especificidade por SubstratoRESUMO
OBJECTIVES: To document the incidence, case fatality, clinical and demographic features of invasive pneumococcal disease in central Australia. DESIGN: Invasive isolates from the regional central laboratory were prospectively recorded over five years and case notes retrospectively reviewed. Population denominators were calculated from national Census data from 1986 and 1991. RESULTS: The population estimates for the region were 14,568 for Aboriginals and 28,680 for non-Aboriginals. There were 185 episodes of invasive pneumococcal disease over the five years, 162 (87.5%) in Aboriginals and 23 (12.5%), in non-Aboriginals. The incidence in Aboriginal children under two years of age was 2052.7 per 100,000 and for those 20-59 years was 178.2 per 100,000. The relative risk in Aboriginals compared with non-Aboriginals was 10.8 (95% CI, 5.6-20.7; P < 0.0001) for those aged 0-4 years and 20.4 (95% CI, 9.7-42.5; P < 0.0001) for those 15-59 years. Forty-one Aboriginal adults aged over 14 (62%) had at least one conventional risk factor for pneumococcal disease; alcohol abuse was present in 27 (41%). There were 13 Aboriginal deaths and the case fatality rose from 2% in those under four years to 40% for those over 59 years. CONCLUSIONS: Central Australian Aboriginals have the highest incidence of invasive pneumococcal disease reported. The rate for children under two years is 59 to 80 times the rates for children in the United States and Sweden. These data have implications for improving vaccine use, health service delivery and environmental health in Aboriginal communities.
Assuntos
Havaiano Nativo ou Outro Ilhéu do Pacífico/estatística & dados numéricos , Infecções Pneumocócicas/epidemiologia , Adolescente , Adulto , Austrália/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Infecções Pneumocócicas/microbiologia , Vigilância da População , Estudos Prospectivos , Estudos Retrospectivos , Fatores de Risco , SorotipagemRESUMO
Tissue factor (TF) is the major activator of the coagulation protease cascade and contributes to lethality in sepsis. Despite several studies analyzing TF expression in animal models of endotoxemia, there remains debate about the cell types that are induced to express TF in different tissues. In this study, we performed a detailed analysis of the induction of TF mRNA and protein expression in two rabbit models of endotoxemia to better understand the cell types that may contribute to local fibrin deposition and disseminated intravascular coagulation. Northern blot analysis demonstrated that lipopolysaccharide (LPS) increased TF expression in the brain, lung, and kidney. In situ hybridization showed that TF mRNA expression was increased in cells identified morphologically as epithelial cells in the lung and as astrocytes in the brain. In the kidney, in situ hybridization experiments and immunohistochemical analysis showed that TF mRNA and protein expression was increased in renal glomeruli and induced in tubular epithelium. Dual staining for TF and vWF failed to demonstrate TF expression in endothelial cells in LPS-treated animals. These results demonstrate that TF expression is induced in many different cell types in LPS-treated rabbits, which may contribute to local fibrin deposition and tissue injury during endotoxemia.